Clinical Trials Logo

Filter by:
NCT ID: NCT06117514 Completed - Healthy Clinical Trials

Sudapyridine (WX-081) in Healthy Volunteers

Start date: February 13, 2019
Phase: Phase 1
Study type: Interventional

The objective of this study is to evaluate the safety, tolerability as well as pharmacokinetics of Sudapyridine (WX-081) in Chinese volunteers.

NCT ID: NCT06116955 Completed - Bronchoscopy Clinical Trials

The Application of Balanced Propofol Sedation in Fiberoptic Bronchoscopy

Start date: September 21, 2023
Phase:
Study type: Observational

The purpose of this study is to investigate the feasibility of using balanced propofol sedation for bronchoscopy. And screen out the optimal balanced propofol sedation compatibility plan.

NCT ID: NCT06116162 Completed - Clinical trials for CO2 Fractional Laser Treatment by Using Acupulse Device

Comparison of SVF-gel Filling and CO2 Fractional Laser on Atrophic Acne Scar Treatment

Start date: January 20, 2021
Phase: N/A
Study type: Interventional

Background Adipose extracellular matrix/stromal vascular fraction gel(SVF-gel), which contains adipose-derived stem cells, endothelial cells, smooth muscle cells, pericytes, and other cell components. Objective To determine the efficacy and safety of SVF-gel for treating acne scars and to compare the results with CO2 fractional laser. Methods Seventeen patients with moderate to severe acne scars were treated with SVF-gel filling and CO2 fractional laser through a 24-week, randomized split-face study. One randomly assigned half side of each patient's received one SVF-gel filling treatment and the other side by two CO2 fractional laser treatment once one months. Clinical improvement was assessed by two blinded investigators with Echelle d'Evaluation Clinique des Cicatrices d'acne (ECCA) scale, VISIA and Antaro-3D detection.

NCT ID: NCT06115837 Completed - Colorectal Cancer Clinical Trials

Prognosis Stratification for pT4bN0M0 Colorectal Cancer Following Multivisceral Resection

Start date: September 1, 2023
Phase:
Study type: Observational

The purpose of this study was to identify the prognostic factors of affecting pT4bN0M0 colorectal cancer patients, so as to better stratify the prognostic differences among patients with the same stage.

NCT ID: NCT06115681 Completed - Clinical trials for Dedifferentiated Liposarcoma

Real-world Study of Dedifferentiated Liposarcoma Patients in China

Start date: March 13, 2024
Phase:
Study type: Observational

This study will characterize patients with dedifferentiated liposarcoma (DDLPS) in China, including an understanding of demographic, and clinical characteristics as well as treatment patterns and clinical outcomes associated with the current real-world treatment.

NCT ID: NCT06114342 Completed - Clinical trials for Major Depressive Disorder

The Biological Specificity of Acupoints Between Major Depressive Disorder Patients and Healthy Controls

Start date: January 10, 2022
Phase:
Study type: Observational

Evidence-based medicine suggests that acupuncture can improve major depressive disorder (MDD). However, the prevalent reliance on experiential acupoint selection lacks scientific underpinning. The investigators conducted a comparative study involving MDD patients and healthy subjects, employing modern techniques to discern biological specificity in MDD-related acupoints. Additionally, the investigators investigated potential correlations between acupoint biological specificity and MDD severity.

NCT ID: NCT06109974 Completed - COPD Clinical Trials

Evaluate the Accuracy of a COPD Screening Algorithm Model

Start date: September 13, 2022
Phase:
Study type: Observational

Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases. Early detection and treatment are critical to prevent the deterioration of COPD. In this study, we have established an algorithm that can detect and infer the severity of COPD from physiological parameters and audio data collected by wearable devices, and in this stage, we aim to evaluate the accuracy of this algorithm.

NCT ID: NCT06109636 Completed - Clinical trials for Corneal Biomechanics

Correlation Analysis Between Corneal Biomechanics and Anterior Segment

Start date: March 4, 2023
Phase:
Study type: Observational

Evaluation of the ciliary muscle thickness, area, and anterior chamber angle, as well as anterior sclera thickness in subjects, to investigate the relationship between these measurements and corneal biomechanics. Clarify whether aqueous humor displacement, anterior sclera, and ciliary muscles influence the assessment of in vivo corneal biomechanics.

NCT ID: NCT06107790 Completed - Clinical trials for HER2-positive Breast Cancer

Phase III Clinical Trial Comparing the Safety, Efficacy, and Immunogenicity of HS022 and Trastuzumab® in Combination With Vinorelbine Bitartrate Injection in the Treatment of HER2-positive Breast Cancer

Start date: May 16, 2018
Phase: Phase 3
Study type: Interventional

This is a multi-center, randomized, double-blind, parallel-group study to evaluate the efficacy and safety and Immunogenicity of Vinorelbine Bitartrate Injection in Combination With HS022 and Trastuzumab®.There were 2 parts. Part 1 needs 8 treatment cycles ( at least 24 weeks); Part2 needs 9 treatment cycles (at least 27 weeks).

NCT ID: NCT06107049 Completed - Poor Quality Sleep Clinical Trials

the Effect of Probiotic on Sleep Quality Management

Start date: November 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about the improvement of sleep quality of probiotic BLa 80 in 110 healthy college students. The main question it aims to answer is whether probiotic BLa80 can effectively improve the sleep quality of college students. The experiment commenced with participants continuously consuming the recommended amount of the probiotic powder for approximately 8 weeks. Simultaneously, they were required to fill out an "Effect Evaluation Form" every week and submit it to relevant department. At the end of the first and eighth weeks, participants underwent tests for five liver functions, four lipid profiles, blood sugar, and uric acid levels, as well as stool sample collection. They then completed the "Mid-Term Effect Evaluation Form".